Zenotech Laboratories schedules board meeting on April 29, 2026 to approve audited standalone financial results for Q4 and FY ending March 31, 2026.
Trading window closure remains effective from April 1 to May 1, 2026, extending 48 hours post-results declaration.
Disclosure made under SEBI Listing Regulations Regulation 29 for mandatory corporate event intimation.